BPG is committed to discovery and dissemination of knowledge
Review
©The Author(s) 2025.
World J Gastrointest Oncol. Oct 15, 2025; 17(10): 108514
Published online Oct 15, 2025. doi: 10.4251/wjgo.v17.i10.108514
Table 1 Summary of key molecular and cellular pathways in colitis-associated colorectal cancer
Pathway/cell type
Key mediators
Biological role
Impact on tumorigenesis
IL-6/JAK/STAT3 pathwayIL-6, JAK, STAT3Promotes epithelial proliferation and inhibits apoptosisFacilitates CI and epithelial transformation
NF-κB signalingNF-κB, TNF-αControls immune and inflammatory gene expressionSustains pro-tumorigenic inflammation
TGF-β pathwayTGF-β, TGFBR2Regulates epithelial growth; normally anti-proliferativeLoss or mutation promotes tumor progression
SOCS3 regulationSOCS3Inhibits STAT3-mediated signalingDysregulation leads to enhanced inflammation and carcinogenesis
MAPK/ASK1 signalingASK1Mediates stress response and immune modulationASK1 deficiency exacerbates inflammation and susceptibility to cancer
CD4+ T helper cellsIL-17, IL-22, IL-9Stimulate epithelial regeneration and immune activationPromote dysplasia and tumor development
Macrophages (M1/M2)IL-13, CCL17 (M2), TNF-α (M1)M1: Antitumor; M2: Tumor-promoting via immunosuppression and cytokine releaseHigh M2 infiltration is linked to poor prognosis and metastasis
Regulatory T cellsFOXP3, IL-10Maintain immune tolerance and suppress inflammationDual role: Contextually antitumor or tumor-permissive
Tumor-infiltrating leukocytesVarious cytokines and chemokinesOrchestrate local immune responseServe as prognostic markers; role depends on cellular composition
S100 family proteinsS100A9, S100A8Mediate inflammation and immune cell recruitmentCorrelated with tumor progression; potential therapeutic targeting


Write to the Help Desk